APR 13, 2017 7:30 AM PDT

The Essential Role of the Molecular Identification of Microorganisms in the Management of Chronic Infections

Speaker

Abstract

Microorganisms growing in biofilm phenotype are the cause of chronic infections.  Several universal properties of biofilm communities are they are overwhelmingly polymicrobial, difficult to culture (viable but not culturable), and the individual constituents are very tolerant of antimicrobial agents, especially antibiotics.  Just like in medical imaging utilizes multiple technological platforms such as ultrasound, magnetic resonance or x-ray, microbial identification requires multiple technologies and methods.  However, when dealing with biofilm phenotype microorganisms, molecular methods are superior.  Molecular methods have the ability to identify microorganisms with very high sensitivity, specificity and also can be quantitative.  Utilizing a quantitative PCR methodology, specific targets can be identified as present/not present but also an absolute quantitative determination for each target present can be made.  This allows for the determination of “bacterial load”.  Sequencing platforms can reveal crucial relative quantification of the different microorganisms present, allowing for the determination of dominant microbes.  Timely and accurate diagnostic information of microorganisms, which are the primary cause of the chronic infection, are essential for improving outcomes.  PCR information can be returned rapidly, allowing the clinician to rule out antibiotic resistant microbes which allows for the selection of appropriate empiric antibiotics.  Sequencing data, which returns several days later, allows for great sensitivity and specificity in the identification of microorganisms while also providing the information on what is dominant within the community.  Antibiotic therapy can then be tailored to the chronic infection.  Molecular diagnosis also provides a way to assess the efficacy of treatment.  Chronic infections are more prevalent and costly than heart disease, cancer, diabetes or any other disease in our healthcare system.  Molecular methods for identifying microorganisms provide a powerful diagnostic tool for the management of chronic infections. 


Show Resources
You May Also Like
OCT 05, 2022 9:00 AM PDT
C.E. CREDITS
OCT 05, 2022 9:00 AM PDT
Date: October 05, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CEST) Candida auris is a multi-drug resistant yeast that continues to be a global threat for infection and transmission in h...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
AUG 16, 2022 11:00 AM PDT
AUG 16, 2022 11:00 AM PDT
Date: August 16, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Understanding genomic variation in the context of cancer is paramount to identifying disease drivers and informing pers...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
AUG 10, 2022 10:00 AM PDT
AUG 10, 2022 10:00 AM PDT
Date: August 10, 2022 Time: 10:00am PDT, 1:00pm EDT The global pandemic has increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provid...
OCT 12, 2022 8:00 AM PDT
OCT 12, 2022 8:00 AM PDT
First Broadcast: Date: October 12, 2022 Time: 8:00am PDT, 11:00am EDT Second Broadcast: Date: October 12, 2022 Time: 9:00am SGT The new Embedded CryoSPARC Live, now fully integrated with t...
APR 13, 2017 7:30 AM PDT

The Essential Role of the Molecular Identification of Microorganisms in the Management of Chronic Infections



Show Resources
Loading Comments...
Show Resources
Attendees